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ABSTRACT 
Objective: The scheme of the present study is to formulate and evaluate herbal gel prepared from sub- fraction of Buchnania lanazan bark extract 
to augment its wound healing activity. 
Methods: Ethyl acetate fraction of Buchanania lanzan bark (Et- BLB) was sub-fractionated by column chromatography using (7:3 methanol: 
chloroform) solvent system, phytochemical test for Et- BLB and F1- 4 (ethyl acetate sub-fractions 1, 2, 3 & 4 of methanolic extract of BLB); in 
particular total flavonoid and phenolic content to demonstrate existence of anti-oxidant activity. In-vivo wound healing supporting study mediated 
by carrageenan induced paw edema as anti inflammatory activity. Herbal gel was formulated incorporating one of the active sub-fractions 
essentially F4
Results: Total phenolic and flavonoid content of F
 in two concentrations (1% & 5%). Carbopol 934, propylene glycol 400, methyl paraben & quantity sufficient distilled water was used 
to prepare herbal gel; then tri-ethanolamine was added to get neutral pH (6.8 - 7) & gel was evaluated for its spreadability, pH, colour, consistency & 
appearance. Excision & incision models were used to validate and to review enhancement competence of wound healing activity; employing percent 
wound contraction & tensile strength of wounded skin as parameters. Reference standard used was framycetin sulphate cream.  
4 was showing highest flavonoid and phenolic content 83.3 mg/g and 77.8 mg/g respectively. 
Prepared gel was reddish brown in colour with satisfying spreadability, acceptable appearance along with homogeneity and negligible irritation. 
Excision and incision animal wound model, groups treated with F4 
Conclusion: Data from both the models revealed that 5% gel of F
5 % gel and reference standard exhibited significant increase in percentage of 
wound contraction as well as up growth in tensile strength with 177 g (P<0.05) and 181.2 g (P<0.01) respectively. 
4
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 showed significant & enhanced wound healing. 
 
INTRODUCTION 
Varieties of plants are being used in the crude form for wound 
healing but due to lack of their marketed formulations they are not 
being known. The available herbal products incorporated with plant 
extracts have become very popular in the market due to their 
convincing potency and intrinsic satisfaction with rare adverse 
effects. Comparatively one third of all conventional medicines are 
used to treat wounds and skin disorders, when related to only 1.3% 
of leading-edge drugs [1]. 
Buchnania lanzan Spreng. (Syn: Buchanania latifolia Roxb. Family: 
Anacardiaceae), usually being informed as “piyal or chironji” in 
Hindi. It is a medium size tree of 12 to 15 m. hight, with a straight 
trunk. Leaves are oval shaped with diameter 12.5 – 25 x 6.3-12.5 cm, 
broadly oblong, obtuse, glabrescent above and more or less villous 
beneath. Petioles are about 12 mm long, panicles shorter than 
leaves, woolly or velvety. Flowers crowded, small, sessile, greenish 
white, bracts, petals 2.5 mm long, ovate-oblong, sub acute; stamens 
10, a little shorter than the petals; filaments flattened; anthers about 
as long as the filaments; ovaries one perfect, conical, pubescent, four 
others reduced to filaments. Fruits are drupes obliquely lentiform, 8-
12 mm long, green when immature and black at ripened stage; stone 
hard, 2-valved. The tree is found as natural wild in the tropical 
deciduous forest of north, western and central India, mostly in the 
state of Madhya Pradesh, Bihar, Orissa, Andhra Pradesh, 
Chhattisgarh, Jharkhand, Gujarat, Rajasthan and Maharashtra. 
Declination in activity of crude plant 
extract is frequently observed due to the environmental stimulus 
and inconveniency during administration (topically, parentrally or 
orally). Hence, there is a need of modification in conventional 
method of using crude extract in order to know the rational 
understanding of disease mechanism which will provide a scientific 
basis for traditional use of herbal medicine.  
Perusal of ancient literatures (Charak Samhita, Bhavprakash, 
Chakradutta, Chiranjeev Vanaushadhi) revealed that the plant has 
been traditionally used as laxative, astringent, expectorant, 
purgative, binding, cooling and aphrodisiac; removes “kapha;” 
purifies blood; tonic to the body, heart and brain; cures “vata,” 
ulcers, blood diseases, biliousness, fever, thirst, pimples, prickly heat 
and various other skin disorders [2]. 
Wound healing is a complex process of restoring cellular structure 
and layers of tissue together in the damaged tissue to its normal 
state. It consists of 3 phases, namely the inflammatory phase, the 
proliferative phase and the phase of maturation or remodelling. The 
inflammatory phase is characterized by hemostasis and 
inflammation. Proliferative phase consists of epithelialization, 
angiogenesis and collagen deposition. In the maturation phase, the 
wound undergoes contraction resulting in lesser amount of apparent 
scar tissue. Granulation tissue which is formed in the final part of the 
proliferative phase mainly consists of fibroblasts, collagen, edema 
and new blood vessels [8]. 
Bark has been found to prevent 
cyclophosphamide induced genotoxicity and oxidative stress in mice 
[3]. Dry fruits of Buchnania lanzan have been reported to show 
immunostimulant and astringent properties [4]. Kernel from the 
plant is known to posse’s antioxidant and anti inflammatory activity 
[5]. Phytochemical analysis of the plant reveals the presence of 
flavonoid, tannins, glycosides, phenols, steroid, saponin and gallic 
acid and myricetin 3’- rhamnoside-3-galactoside in leaves [6, 7]. 
MATERIALS AND METHODS 
Plant Material 
Buchnania lanzan (Spreng) barks were procured from the campus of 
BIT, mesra, Ranchi Jharkhand in the month of June 2012. The plant 
was identified and authenticated from Central National Herbarium, 
Botanical survey of India (BSI) P.O. Botanical garden, Howrah. [No. – 
CNH/I.I (81) 2005- Tech. II. / 1134]. The Plant specimen Herbarium 
was also submitted in the Department of Pharmaceutical Science 
and Technology, BIT, Mesra, Ranchi. 
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Preparation of plant material 
The barks were dried in shade for 15 days. Once thoroughly dried, 
barks were subjected to size reduction by grinding and after 
subsequent sieving, the powdered mass of bark were subjected to 
extraction with successive cold maceration employing petroleum 
ether, chloroform, ethyl acetate and methanol for 7 days at room 
temperature with intermittent stirring and shaking. The extract 
obtained was decanted and clarified by filtration, then concentrated 
and solvent was recovered by rotatory evaporation. After 
preliminary screening of all the extract, methanolic extract was 
selected for further fractionation using ethyl acetate, n-butanol and 
water. On the ground of various anti- oxidant assays, ethyl acetate 
fraction was selected and proceeded for sub fractionation which was 
accompanied by the range of solvent system; petroleum ether: 
chloroform (1:1; F1), Chloroform (100%; F2), Chloroform: methanol 
(9:1; F3), chloroform: methanol (7:3; F4
The most active sub-fraction F
). 
4 
Phytochemical test of sub- fraction of ethyl acetate extract 
was selected for herbal gel 
preparation and wound healing studies on the strength of its various 
antioxidant assays and In-vivo wound healing supporting screenings. 
Estimation of total Flavonoid content 
0.5 ml of sub fraction of ethyl acetate (100 µg/ml) was infused with 
1.5 ml of methanol (75 % v/v), 0.1 ml of potassium acetate (1 M) & 
2.8 ml of distilled water. The reaction mixture was allowed to 
incubate for 30 min at room temperature before the absorbance was 
taken at 435 nm. Water 0.1 ml was used to substitute aluminium 
chloride for blank. Quercetin was used as standard for the 
calibration curve. The result was expressed as quercetin equivalent 
in mg/g of extract (Table no. 1) [9].  
Estimation of total Phenolic content 
0.1 ml of sub – fraction of ethyl acetate (10 µg/ml) was mixed with 
0.5 ml of folin –ciocalteu reagent (Diluted 1: 10 ratio with distilled 
water) and 1.5 ml of sodium carbonate. The solution was shaken 
thoroughly and made up to the 10 ml by double distilled water. The 
mixture was allowed to stand for 2 hours. The absorbance was 
measured at 750 nm, using gallic acid as standard (2-10 µg/ml). 
Standard plot was obtained. The total phenolic content was expressed as 
gallic acid equivalent in mg/g of the extract (Table no. 2) [19].  
In-vivo supporting study for wound healing 
Anti-inflammatory activity 
Carrageenan-induced rat paw edema method 
In this method, Wistar rats of either sex weighing (200- 250 gm) 
were taken and divided into three groups of three each. The animals 
were pre-treated with standard reference drug and F4
The percent inhibition in increase of edema volume for each animal 
group was calculated by the following formula,  
 in 
concentration of (50 mg/kg) 30 min before carrageenan injection 
(phlogistic agent) of 0.1 ml dose (i.p). Carrageenan was injected into 
the sub plantar region of left hind paw of each rat. Swellings of 
carrageenan-injected foot were measured at 30 min, 60 min, 120 
min, 180 min, using plethysmometer (ALMEMO.2390-5/AHLBORN). 
The right hind paw was injected with 0.1 ml of vehicle. The animals 
received the standard drug declofenac sodium (Alembic Limited) 
(100 mg/kg, i.p.) [21, 22]. This served as reference standard (Table 
no.3).  
% inhibition of edema = 
 (Vt –V0) control – (Vt− V0) treated
(Vt−Vo) control 
 × 100 
Where, Vt = Edema volume at time (t) after carrageenan treatment, 
V0 = Average edema volume of animals taken before oral 
administration of reference standard and F4
Gel Preparation 
. 
The herbal gel was prepared using two different concentration of F4 
(1 % and 5%). Two mixtures were prepared by adding 1 gm 
carbopol 934 (Lubrizol) in distilled water with continuous agitation: 
(A) and Methyl paraben (CDH) (0.5%) in hot water, propyl paraben 
(CDH) (0.2%) in propylene glycol (CDH): (B) [9]. Required quantity 
of F4
Evaluation of herbal topical gel 
 mixed in distilled water with continuous stirring and added to 
mixture A, both the mixture was blended and volume was made up 
to 100 ml. Tri- ethanolamine (Sigma-Aldrich) was added drop wise 
to get neutral pH (6.8 - 7) and to obtain gel of required consistency 
and then prepared gel was packed in a air tight wide mouth 
container. Same procedure was followed for preparation of placebo 
gel (Table no. 4).  
Physical evaluation 
Physical parameters such as the colour and appearance were 
checked. 
Measurement of pH 
pH measurement of formulated gel was executed by employing 
systronics μ pH system 361. By immersion of the glass electrode into 
the formulation.  
Spreadability 
Spreadability was determined by the unit consisting of a glass slide 
provided all that is with a pulley at one end. By this method 
spreadability was measured based on rolling resistance and drag of 
gels. Excess gel (2 g) in-studio has been placed on the ground sheet. 
The gel was then sandwiched between the slides and the other glass 
slide having the dimension of the slide fixed to the ground and 
provided with hook. 25 g weight was placed on top of the two sheets 
for 5 minutes to remove air and to provide a uniform gel film 
between slides. Excess gel was dropped from the edges. The top 
slide is then subjected to pull 80 gm weight with the help of a string 
attached to the hook and the time (in seconds) required by the 
upper slide to cover a distance of 7.5 cm. Shorter interval indicates 
better spreadability. 





Where, S = Spreadability, M = weight in the pan (tied to the upper 
slide), L = Length moved by the glass slide and T = Time (in sec) 
taken to separate the slide completely each other [9].
Homogeneity 
  
All developed gels were tested for homogeneity by visual inspection 
after the gels have been set in the container. They were tested for 
their appearance and presence of any aggregates. 
Skin irritation test 
In the skin irritation study either sex of rats were used. Animals 
were divided into 4 groups. Hairs were depleted from the back of 
mice with the help of depilatories and area 4 cm2
Pharmacological Screening 
 was marked on 
both sides. One side served as control while the other as test and 
animals were used after 24 hours [10]. After hair depletion gel was 
applied by spatula once daily for 7 days and site was covered with 
cotton bandage and observed for sensitivity and the reaction as 
erythema and edema (Table no. 5). 
Experimental animals 
Swiss male albino mice weighing 25–30 g were used in the study. 
Animals were procured from Laboratory Animal House of Birla 
Institute of Technology, Mesra (Reg. no.: 621/02/ac/CPCSEA, Ref no. 
PROV/BIT/PH/IAEC/06/2012/14.10.2010). All animal experiments 
strictly complied with the approval of institutional animal ethical 
committee. The animals were kept in polyacrylic cages and 
maintained under standard housing conditions of temperature (24-
27°C) and humidity (60-65%) with 12:12 light: dark cycles. They 
were acclimatized for seven days. Gel was applied once daily 
topically on wounds for 14 days. 
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Wound healing activity 
Excision wound model 
The male albino mice were divided into 4 groups (n=4) 
Group A: Placebo treated wounded mice 
Group B: 5% gel treated wounded mice  
Group C: 1 % gel treated wounded mice  
Group D: Reference standard treated wounded mice (Framycetin 
sulphate) 
At first the mice were anaesthetized by open mask method using 
ether as anaesthetic agent [11]. Dorsal back of mice was depilated 
and ethyl alcohol (70%) was used as topical antiseptic for the 
depilated dorsal back before wound creation. An excision wound 
was carefully made by removing 7mm 
Linear incision wound model 
×7 mm full thickness area 
from a predetermined area on each mice [12]. The excised wound 
was left undressed to the open environment and microbial agents 
were not at all used. Formulated gel and reference standard was 
applied once daily with sterilized spatula, which will take 
approximately same exact amount of gel. Application of formulated 
gel continued till 14 days, after termination of experiment, animals 
of all the groups treated with reference standard. During the 
experiment wounded animals were also documented 
photographically from fixed distance. The mice were distributed in 
groups and were placed in separate cages.  
Animals in each group were anaesthetized correspondingly as in 
excision wound model and one paravertebral long incision was 
made through the skin and cutaneous at a distance of 1 cm on 
depilated back. After the incision made the parted skin kept together 
and stitched with surgical thread and curved needle [13]. The wound 
was left undressed. Formulated gel and reference standard was 
applied topically with sterilised spatula once daily for 11 days; when 
wounds were cured thoroughly the sutures were removed on 
11th 
Wound healing evaluation parameters 
day and tensile strength was measured. 
Determination of wound contraction  
After surgery the excision wound margins was traced by the 
progressive changes in wound area planimetrically. The size of 
wound was traced on a transparent paper in every 2 days interval 
throughout the monitoring period; measurements were continued 
up to 14 days. The tracing was then shifted to graph paper, from 
which wound surface area was evaluated [14]. 
The wound contraction percentage was determined from the 
measurements using the following formula:  
The evaluated surface 
area was then employed to calculate the percentage of wound 
contraction. Wound contraction was expressed as percentage of 
wound area that had healed.  
% Wound contraction = 
Wound area on day 0 – Wound area on day n
Wound area on day 0
 × 100 
Measurement of tensile strength  
The sutures were removed on the 11th day and mice were 
anaesthetized. Small piece of healed wound was cut such that the 
healed incision wound comes exactly in the middle. Four small 
curved needles were pierced through the healed skin, two on either 
side. On the one side two needles were tied to a rod and the other 
side two needles were tied to a plastic bottle, which hangs freely in 
the air (the either side of needles were placed equidistance from the 
healed incision wound). Then slowly water was added to bottle until 
wound began to open [15]. 
% Tensile strength = Tensile strength of sample – Tensile strength of control 
Tensile strength control
× 100 
The amount of water in the bottle was 
weighed and considered as an indirect measure of the tensile 
strength of the wound. The mean determinations of tensile strength 
on the paravertebral incisions on the animals were taken as the 
measures of the tensile strength of the wound for an individual 
animal.  
Histopathological examination 
After deep ether anaesthesia, the cross – sectional full thickness skin 
specimens from each group were taken out on 10th
Statistical analysis 
 day of the 
experiment for histopathological examinations. The tissue was 
sectioned into very thin (2 – 8 or 5-10 micrometer) sections using 
microtome, then Hematoxylin and eosin stained tissue slides were 
examined under the Leica DME microscope and photographs were 
captured with 7.1 M Pixels Canon power shot for histopathological 
changes for aggregation of macrophages, migration of fibroblasts, 
new blood vessels formation and collagen deposition [16].  
The data were analysed statistically using one – way analysis of 
variance (ANOVA) followed by Dunnett’s t – test. The data were 
expressed as mean ± SEM. P – value less than 0.05 imply 
significance.  
RESULTS AND DISCUSSION 
Total flavonoid and phenolic content 
Total flavonoid content reported that among the other sub- fractions 
of ethyl acetate fraction F4
Anti inflammatory activity 
 reported highest flavonoid content 83.3 
mg/g and phenolic content 77.8 mg/g as compared to ethyl acetate 
fraction 73.3 mg/g and 67.3 mg/g respectively.  
F4
Physical evaluation of gel  
 was showing significant increase in inhibition of paw edema 
value as time elapsed specifically at 1, 2 and 3 hours as compared to 
control. 
The herbal gel prepared was reddish brown in colour, translucent in 
appearance, gave smooth experience on application, pH was found 
6.8 to 7.2, spreadability was also planted to be with less variation, on 
slight agitation gel was evenly and efficiently spreaded, adhered 
suitably to imperative surface area, and absence of lumps indicates 
acceptable homogeneity. Formulated topical gel was non - irritant 
upon application. (Table no. 5) and (Figure no. 1) shows values of 
physical evaluation of all formulations at the time of formulation and 
photographical representation of formulated gel. 
Wound contraction 
Excision wound models showed that all treated animal groups 
exhibited significant increase in the percentage of wound 
contraction as compared to placebo control group on 11th day. 
However, it was seen that the significant healing of wound took 
place in case of animals, which received 5% F4 gel as compared to 
control, photographically exhibited in (Figure no. 2). Among them F4 
5% has shown significant increase in wound contraction on 8th, 11th, 
14th
Tensile Strength 
, day of post wounding day, which was as comparable as that of 
standard treated group. Values of percentage wound contraction on 
different days presented in (Table no.6). 
Tensile strength of incised wounds documented in (Table no. 7), 
animals treated with 5% gel of F4
Histopathological examinations 
 and reference standard showed 
significant increase in tensile strength with 177.5 g (P < 0.05) and 
181.2 g (P < 0.01) respectively, compared with tensile strength of 
control Placebo group, i.e., 148.6 g.  
Histopathological examination revealed the wound healing process 
of the wounded tissue showed in (Figure no.3). Mice which received 
topical application with 5% gel of F4 was comparably close to the 
reference standard drug and its sections of tissue also observed with 
less aggregation of macrophages, enhanced migration of fibroblasts 
cells, formation of new blood vessels and well collagen deposition 
indicates nearly complete healing of wound in the 10th post 
wounding day.  
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CONCLUSION 
Wound healing can be discussed in three phases viz. Inflammatory 
phase, proliferative phase and maturational or remodelling phase 
[8]. And it is a multifactorial process that results in contraction and 
closure of the wound and restoration of a functional barrier. It is 
consented that reactive oxygen species (ROS) are deleterious to 
wound healing process due to the harmful effects on cells and 
tissues [17]. Numbers of constituents grounded in plant extract are 
potent anti–oxidants and have strong antimicrobial activity, as 
plants are root of many naturally occurring flavonoids and other 
phenolic compounds, higher the content of these flavonoids and 
phenolic compounds, higher the antioxidant activity which plays 
critically influential aspect in enhancing wound healing activity. F4  
was selected on the ground of compelling range of antioxidant 
activities. Wound surface area essentially should have moist 
environment, possible mechanism explaining the observed 
improved healing include easier migration of epidermal cells over 
the moist wound surface instead of under a dry scab, increased 
partial pressure of oxygen, & the preservation of growth factors and 
protienases present in fluid exudates that are hence allowed to exert 
their potentiating effect on wound healing [18]. Epithelial layer that 
seals and protects the wound from bacteria and fluid loss, needs 
moist environment for its formation and foster growth. The layer is 
very much fragile that can be easily destroyed by with aggressive 
wound irrigation, hence due to adherence of drug along with help of 
formulated gel with higher concentration of F4
S. No. 
 to imperative surface 
area provides moist environment which enhances the formation of 
epithelial layer by protecting it from external adversity and stress, 
by providing anti-microbial and anti-oxidant effect.  
 
Table 1: Total flavonoid content of Et-BLB and sub-fractions of BLB 
Fractions Total flavonoid content 
(mg/g) 
1.  Ethyl acetate 73.3 
2.  Sub-fraction 1 16 
3.  Sub-fraction 2 6.6 
4.  Sub-fraction 3 40 
5.  Sub-fraction 4 83.3 
 
Table 2: Total Phenolic content of Et-BLB and sub-fractions of BLB 
S. No. Fractions Total phenolic content (mg/g) 
1.  Ethyl acetate 67.3 
2.  Sub-fraction 1 37 
3.  Sub-fraction 2 36 
4.  Sub-fraction 3 40 
5.  Sub-fraction 4 77.8 
 
Table 3: Carrageenan-induced hind paw edema in rats. 
S. No. Treatment Dose 
(mg/kg) 
Paw edema (ml) 
Mean ± SE 
30 min 1 hr 2 hr 3 hr 
1.  Control - 0.425 ±.078 0.725 ± 0.085 0.775 ± 0.094 0.625 ± 0.137 
2.  Standard 
(Diclofenac Sodium) 
100 0.175 ± 0.3* 
(52.63) 
0.2 ± 0.00** 
(72.41) 
0.1 ± 0.041** 
(87) 
.05 ± 0.028** 
(92) 








Values in brackets are % inhibition of edema,  Each value is the mean ± S.E.M, n=4, EV: edema volume; EI: edema inhibition, *P < 0.05 vs. control, 
One way ANOVA followed by Dunnet’s t-test. **p < 0.01 vs. control, One way ANOVA followed by Dunnet’s t-test. 
 
Table 4: Preparation of placebo gel and gel with F
Contents 
4 
Placebo gel Gel (1%) Gel (5%) 
Carbopol (g) 1 1 1 
Methyl Paraben (0.5%)(ml) 0.2 0.2 0.2 
Propyl Paraben (0.2%)(ml) 0.1 0.1 0.1 
Propylene Glycol (ml) 5 5 5 
Triethanolamine (ml) 1.2 1.2 1.2 
Extract(g) - 1 5 
 
Table 5: Physical evaluation of all formulations at the time of gel formulation 
Formulation Colour Appearance Spreadability 
(g.cm/sec) 
pH 
Placebo Gel White Clear and Transparent 13.2 7.0 
F4 Reddish brown  gel 1% Clear and Translucent 10 6.8 
F4 Reddish brown gel 5% Clear and Translucent 8 7.2 
 
Table 6: Wound healing activity of F4
S. No. 
 and standard by excision wound model in mice 
Post wounding days Percentage wound contraction (Mean ± SEM) 
Standard 
(Framycetin Sulphate) 




1.  2 1.135 ± 0.1775 0.945 ± 0.098 1.025 ± 0.165 0.955 ± 0.085 
2.  5 17.563 ± 3.237* 5.630 ± 0.739 12.30 ± 3.678 10.58 ± 1.230 
3.  8 52.53 ± 3.050** 34.53 ± 2.120 50.76 ± 1.244* 43.07 ± 2.730 
4.  11 87.60 ± 1.766** 41.03 ± 3.736 74.20 ± 1.776** 62.40 ± 2.184* 
5.  14 92.50 ± 0.860** 62.48 ± 1.167 85.12 ± 1.430** 64.38 ± 2.889 
Values are expressed as mean ± SEM (N=4), *P<0.05, **P< 0.01 When compared to control. One way ANOVA followed by Dunnet’s t-test. 
 
 
Table 7: Wound healing activity of F4 
S. 
No. 
and standard by incision 
wound model in mice. 
No. of 
animals 
Treatment Tensile strength (g) 
(Mean ± SEM) 
1.  4 Control 148.6 ± 4.110 
2.  4 Standard 
(Framycetin 
sulphate) 
181.2 ± 1.391** 
3.  4 F4  177.5 ± 3.285* (5% gel w/w) 
4.  4 F4 153.4 ± 3.423  (1% gel w/w) 
Values are expressed as mean ± SEM (N=4), *P<0.05, **P<0.01 When 
compared to control. One way ANOVA followed by Dunnet’s t-test. 
 
 
Fig. 1: Photographical representation of formulated gel 
 
 
Fig. 2: Photographical representation of wound contraction on 
different days (0 - 14) by excision wound model in mice,  
A- Placebo treated group;  
B- Framycetin Sulphate treated group;  
C- F4 gel (5%) treated group; D- F4
 
 gel treated group (1%). 
Fig. 3: Photomicrographs of hematoxylin and eosin stained sections 
of granulation tissue obtained from the animal wounds of,  
A - Placebo treated group shows more aggregation of macrophages (M), 
poor migration of fibroblasts cells (F) and less collagen (C) formation 
which is not significant indicates incomplete healing of wound;  
B - Framycetin Sulphate treated group shows fewer aggregation of 
macrophages, increased migration of fibroblasts cells, formation of 
new blood vessels and increased collagen deposition indicates 
complete healing of wound;  
C - F4
D - F
 gel (5%) treated group shows less aggregation of 
macrophages, enhanced migration of fibroblasts cells, formation of 
new blood vessels and enhanced collagen deposition indicates 
nearly complete healing of wound;  
4
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